The challenge of drug approval in rare cancers
Pexidartinib has emerged as a promising treatment option for patients with advanced tenosynovial giant cell tumors and could demonstrate encouraging long-term control in this patient population. This editorial aims to pick out as a central theme the complex and somehow unfortunate registration statu...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2021
|
| In: |
Cancer
Year: 2021, Volume: 127, Issue: 6, Pages: 837-839 |
| ISSN: | 1097-0142 |
| DOI: | 10.1002/cncr.33314 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/cncr.33314 Verlag, lizenzpflichtig, Volltext: https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.33314 
|
| Author Notes: | Bernd Kasper |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1767090455 | ||
| 003 | DE-627 | ||
| 005 | 20230426082437.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210816s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cncr.33314 |2 doi | |
| 035 | |a (DE-627)1767090455 | ||
| 035 | |a (DE-599)KXP1767090455 | ||
| 035 | |a (OCoLC)1341420271 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kasper, Bernd |d 1974- |e VerfasserIn |0 (DE-588)12274764X |0 (DE-627)082130736 |0 (DE-576)29340447X |4 aut | |
| 245 | 1 | 4 | |a The challenge of drug approval in rare cancers |c Bernd Kasper |
| 264 | 1 | |c 2021 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published: 16 November 2020 | ||
| 500 | |a Gesehen am 16.08.2021 | ||
| 520 | |a Pexidartinib has emerged as a promising treatment option for patients with advanced tenosynovial giant cell tumors and could demonstrate encouraging long-term control in this patient population. This editorial aims to pick out as a central theme the complex and somehow unfortunate registration status of pexidartinib in Europe in comparison with the United States. | ||
| 650 | 4 | |a pexidartinib | |
| 650 | 4 | |a rare cancer | |
| 650 | 4 | |a registration | |
| 650 | 4 | |a soft tissue sarcoma | |
| 650 | 4 | |a TGCT | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer |d New York, NY : Wiley-Liss, 1948 |g 127(2021), 6, Seite 837-839 |h Online-Ressource |w (DE-627)271350334 |w (DE-600)1479932-7 |w (DE-576)078590884 |x 1097-0142 |7 nnas |a The challenge of drug approval in rare cancers |
| 773 | 1 | 8 | |g volume:127 |g year:2021 |g number:6 |g pages:837-839 |g extent:3 |a The challenge of drug approval in rare cancers |
| 856 | 4 | 0 | |u https://doi.org/10.1002/cncr.33314 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.33314 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210816 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 12274764X |a Kasper, Bernd |m 12274764X:Kasper, Bernd |d 60000 |e 60000PK12274764X |k 0/60000/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1767090455 |e 3969257611 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"The challenge of drug approval in rare cancers","title_sort":"challenge of drug approval in rare cancers"}],"language":["eng"],"person":[{"given":"Bernd","role":"aut","display":"Kasper, Bernd","family":"Kasper"}],"name":{"displayForm":["Bernd Kasper"]},"physDesc":[{"extent":"3 S."}],"id":{"doi":["10.1002/cncr.33314"],"eki":["1767090455"]},"relHost":[{"recId":"271350334","origin":[{"publisher":"Wiley-Liss","dateIssuedDisp":"1948-","dateIssuedKey":"1948","publisherPlace":"New York, NY"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Cancer cytopathology"}],"note":["Gesehen am 06.12.2011"],"id":{"issn":["1097-0142"],"zdb":["1479932-7"],"doi":["10.1002/(ISSN)1097-0142"],"eki":["271350334"]},"disp":"The challenge of drug approval in rare cancersCancer","physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1948 -"],"part":{"volume":"127","text":"127(2021), 6, Seite 837-839","year":"2021","issue":"6","pages":"837-839","extent":"3"},"language":["eng"],"title":[{"subtitle":"interdisciplinary international journal of the American Cancer Society","title":"Cancer","title_sort":"Cancer"}]}],"note":["First published: 16 November 2020","Gesehen am 16.08.2021"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"2021"}],"recId":"1767090455","type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a KASPERBERNCHALLENGEO2021 | ||